首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Neoplasia

缩写:NEOPLASIA

ISSN:1476-5586

e-ISSN:1476-5586

IF/分区:7.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2192
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kassidy M Jungles,Caroline R Bishop,Cydnee M Wilson et al. Kassidy M Jungles et al.
Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype that disproportionately impacts Black women and has limited effective therapeutic options. Consequently, there is an urgent need to develop novel approaches for the...
Mohamed Kamal,Stephanie N Shishido,Jeremy Mason et al. Mohamed Kamal et al.
Multiple myeloma (MM) is an aggressive hematologic malignancy arising from plasma cell (PC) proliferation in the bone marrow, progressing from its precursor states MGUS and SMM. Despite therapeutic advances, MM remains incurable, underscori...
Hsuan-Yu Peng,Kwang-Yu Chang,Wei-Min Chang et al. Hsuan-Yu Peng et al.
Oral squamous cell carcinoma (OSCC) is an aggressive malignancy frequently characterized by dysregulated epidermal growth factor receptor (EGFR) signaling. Among EGFR mutation, EGFRvIII, an extracellular domain truncated form without exons ...
Yuling Chi,Shireen Chikara,Eduardo Mere Del Aguila et al. Yuling Chi et al.
Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer in adults. We generated TRAnsgenic of Cancer of the Kidney (TRACK) mice that express a triple-mutant (P402A, P564A, and N803A) human HIF1α construct specifica...
Xiaoyue He,Xiaohong Xia,Ziying Lei et al. Xiaoyue He et al.
The overexpression and amplification of HER2 occurs in breast cancer. However, the mechanism of HER2 action in tumor has not yet been elucidated. HER2 can be degraded by the UPS system, and several HER2-associated E3s have been identified, ...
Maria Malvina Tsamouri,Stephen J Libertini,Salma Siddiqui et al. Maria Malvina Tsamouri et al.
The androgen receptor (AR) is a pivotal regulator of growth and survival of prostate cancer (PCa) and the majority of lethal castration-resistant prostate cancers (CRPC) remain reliant on AR signaling. PCa exhibits variability in progressio...
Zaineb Hassouneh,Onika D V Noel,Niannian Ji et al. Zaineb Hassouneh et al.
Bladder cancer (BCa) exhibits favorable responses to immunotherapy, but a significant percentage of patients fail to show a response owing to an inadequate tumor-immune landscape. We previously showed that NK cells are one of the predominan...
Ke Ma,Qinyu Li,Yi Zhang et al. Ke Ma et al.
Clear cell renal cell carcinoma (ccRCC) is strongly aetiologically associated with von Hippel‒Lindau (VHL) tumour suppressor gene mutations, which result in constitutive activation of hypoxia-inducible factors and pathological angiogenesis...
Yun Lu,Jonathan Moye,Adriana V F Massicano et al. Yun Lu et al.
Introduction: Triple-negative breast cancer (TNBC) lacks targeted therapies due to an absence of biomarkers, making chemotherapy the primary treatment option for early-stage cancer. This study evaluates whether the order ...